# National Cancer Institute Early Career Cancer Clinical Investigator Award

> **NIH NIH P30** · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · 2024 · $60,000

## Abstract

Project Summary/Abstract
Dr. George has ongoing clinical trials that are evaluating novel combinations for the management of breast
cancer. This supplement will support the collaborative efforts between clinical investigators and basic scientists
to investigate biomarker driven strategies for further investigations. Based on these results, larger multi-
institutional studies will be opened within ETCTN and cooperative groups to propel therapeutic advancements
in breast cancer. Our goals and objectives align with the goals of the NCI to advance broad spectrum of cancer
research to develop effective tolerable therapies for our patients.

## Key facts

- **NIH application ID:** 11002170
- **Project number:** 3P30CA072720-25S1
- **Recipient organization:** RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- **Principal Investigator:** STEVEN K. LIBUTTI
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $60,000
- **Award type:** 3
- **Project period:** 1997-03-01 → 2029-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11002170

## Citation

> US National Institutes of Health, RePORTER application 11002170, National Cancer Institute Early Career Cancer Clinical Investigator Award (3P30CA072720-25S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11002170. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*